338 related articles for article (PubMed ID: 21750108)
1. Loss of exon identity is a common mechanism of human inherited disease.
Sterne-Weiler T; Howard J; Mort M; Cooper DN; Sanford JR
Genome Res; 2011 Oct; 21(10):1563-71. PubMed ID: 21750108
[TBL] [Abstract][Full Text] [Related]
2. MutPred Splice: machine learning-based prediction of exonic variants that disrupt splicing.
Mort M; Sterne-Weiler T; Li B; Ball EV; Cooper DN; Radivojac P; Sanford JR; Mooney SD
Genome Biol; 2014 Jan; 15(1):R19. PubMed ID: 24451234
[TBL] [Abstract][Full Text] [Related]
3. Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.
Nielsen KB; Sørensen S; Cartegni L; Corydon TJ; Doktor TK; Schroeder LD; Reinert LS; Elpeleg O; Krainer AR; Gregersen N; Kjems J; Andresen BS
Am J Hum Genet; 2007 Mar; 80(3):416-32. PubMed ID: 17273963
[TBL] [Abstract][Full Text] [Related]
4. Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease.
Claverie-Martin F; Gonzalez-Paredes FJ; Ramos-Trujillo E
RNA Biol; 2015; 12(4):369-74. PubMed ID: 25757501
[TBL] [Abstract][Full Text] [Related]
5. Determinants of the Usage of Splice-Associated cis-Motifs Predict the Distribution of Human Pathogenic SNPs.
Wu X; Hurst LD
Mol Biol Evol; 2016 Feb; 33(2):518-29. PubMed ID: 26545919
[TBL] [Abstract][Full Text] [Related]
6. Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse.
Buvoli M; Buvoli A; Leinwand LA
PLoS One; 2007 May; 2(5):e427. PubMed ID: 17487273
[TBL] [Abstract][Full Text] [Related]
7. Vulnerable exons, like ACADM exon 5, are highly dependent on maintaining a correct balance between splicing enhancers and silencers.
Holm LL; Doktor TK; Hansen MB; Petersen USS; Andresen BS
Hum Mutat; 2022 Feb; 43(2):253-265. PubMed ID: 34923709
[TBL] [Abstract][Full Text] [Related]
8. Identification of a splicing enhancer in MLH1 using COMPARE, a new assay for determination of relative RNA splicing efficiencies.
Xu DQ; Mattox W
Hum Mol Genet; 2006 Jan; 15(2):329-36. PubMed ID: 16357104
[TBL] [Abstract][Full Text] [Related]
9. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
[TBL] [Abstract][Full Text] [Related]
10. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
[TBL] [Abstract][Full Text] [Related]
11. Skipping of an exon with a nonsense mutation in the DMD gene is induced by the conversion of a splicing enhancer to a splicing silencer.
Zhu Y; Deng H; Chen X; Li H; Yang C; Li S; Pan X; Tian S; Feng S; Tan X; Matsuo M; Zhang Z
Hum Genet; 2019 Jul; 138(7):771-785. PubMed ID: 31168774
[TBL] [Abstract][Full Text] [Related]
12. Genomic features defining exonic variants that modulate splicing.
Woolfe A; Mullikin JC; Elnitski L
Genome Biol; 2010; 11(2):R20. PubMed ID: 20158892
[TBL] [Abstract][Full Text] [Related]
13. Splicing mutations in human genetic disorders: examples, detection, and confirmation.
Anna A; Monika G
J Appl Genet; 2018 Aug; 59(3):253-268. PubMed ID: 29680930
[TBL] [Abstract][Full Text] [Related]
14. Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.
Zheng ZM
J Biomed Sci; 2004; 11(3):278-94. PubMed ID: 15067211
[TBL] [Abstract][Full Text] [Related]
15. General and specific functions of exonic splicing silencers in splicing control.
Wang Z; Xiao X; Van Nostrand E; Burge CB
Mol Cell; 2006 Jul; 23(1):61-70. PubMed ID: 16797197
[TBL] [Abstract][Full Text] [Related]
16. Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition.
Královicová J; Vorechovsky I
Nucleic Acids Res; 2007; 35(19):6399-413. PubMed ID: 17881373
[TBL] [Abstract][Full Text] [Related]
17. Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
Heintz C; Dobrowolski SF; Andersen HS; Demirkol M; Blau N; Andresen BS
Mol Genet Metab; 2012 Aug; 106(4):403-11. PubMed ID: 22698810
[TBL] [Abstract][Full Text] [Related]
18. Exonic Variants that Affect Splicing - An Opportunity for "Hidden" Mutations Causing Inherited Retinal Diseases.
Sundaresan Y; Banin E; Sharon D
Adv Exp Med Biol; 2023; 1415():183-187. PubMed ID: 37440032
[TBL] [Abstract][Full Text] [Related]
19. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
Gorlov IP; Gorlova OY; Frazier ML; Amos CI
Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
[TBL] [Abstract][Full Text] [Related]
20. Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6.
Raponi M; Kralovicova J; Copson E; Divina P; Eccles D; Johnson P; Baralle D; Vorechovsky I
Hum Mutat; 2011 Apr; 32(4):436-44. PubMed ID: 21309043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
